Myasthenia gravis and myasthenic syndrome

@article{Antozzi2003MyastheniaGA,
  title={Myasthenia gravis and myasthenic syndrome},
  author={Carlo Giuseppe Antozzi},
  journal={Neurological Sciences},
  year={2003},
  volume={24},
  pages={s260-s263}
}
Myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are autoimmune ion channel disorders mediated by antibodies to postsynaptic acetylcholine receptors and presynaptic voltage-operated calcium channels, respectively. MG and LEMS are currently treated with corticosteroids and immunosuppressive drugs with a positive clinical outcome. Since both diseases are mediated by circulating autoantibodies, they are good candidates for immunomodulation by intravenous immunoglobulins (IVIG… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 22 references

High-dose intravenous immunoglobulin G treatment of myasthenia gravis

Neurological Sciences • 2002
View 3 Excerpts
Highly Influenced

Plasma exchange for myasthenia gravis.

The Cochrane database of systematic reviews • 2002
View 2 Excerpts

The Lambert-Eaton myasthenic syndrome.

Clinical reviews in allergy & immunology • 2001
View 1 Excerpt

Similar Papers

Loading similar papers…